Hba1c Testing Device Market Expected to reach USD 2.20 billion by 2021

Hba1c Testing Device Market

According to the report, the global HbA1c testing device market accounted for around USD 1.20 billion in 2015 and is expected to reach approximately USD 2.20 billion by 2021, growing at a CAGR of around 11 % between 2016 and 2021.

Request for Free Sample Report @ goo.gl/JiM5xz

Hemoglobin is the red protein molecule responsible for carrying oxygen from lung to the body’s organ and tissues. Glucose molecule sticks to the N-terminal amino acid of the hemoglobin molecule by nonenzymatic attachment to form a hemoglobin A1c or HbA1c, also called as glycosylated hemoglobin molecule.  Diabetes mellitus is a common form of diabetes, caused by pancreatic insulin deficiency, which affects metabolization of starch and sugar.  HbA1c level reflects the average glucose concentration over the previous period and provides a much better indication of body glucose control than urinary and blood glucose determinations.

The growth of HbA1c testing device market is propelled by increasing number of diabetes population. Geriatric and obese populations are more prone to diabetes mellitus. Globally, USD 673 billion healthcare expenditure is spent on diabetes management which is 12% of total healthcare expenditure. In 2015, around 5.0 million deaths are due to diabetes.  Moreover, emerging technologies for diabetes management and increasing awareness of diabetes preventive care are projected to fuel the growth of HbA1c testing device market. In addition, increasing doctor’s prescription pattern for HbA1c testing is a key factor for generating more demand for the HbA1c testing device. On another hand, the high cost of device and limitation of results of the certain population like pregnant, elderly and non-Hispanic black could be a roadblock in the market. Nonetheless, untapped market and increasing demand for medical tourism in emerging markets are likely to open new opportunities in the forecast period.

Ask to Analyst @ goo.gl/TSKttT

Global HbA1c Testing Device market

Based on the device type, the market of the HbA1c testing device has been classified into the handheld device and bench-top device. Bench-top HbA1c testing device is widely used in the diagnostic laboratory due to minimal handling and fastest & accurate results. Bench-top HbA1c testing device segment has acquired the largest market share of more than 65% in 2015 compared to the handheld device and in forecast period handheld HbA1c testing device is projected to grow at the healthy rate.

Based on the technology the market of the HbA1c testing device has been segmented as ion-exchange HPLC, enzymatic assay, affinity binding chromatography, turbidimetric inhibition immunoassay and other. With more than 30% revenue contribution, affinity binding chromatography segment was leading the HbA1c testing device market in 2015 due to increasing investment by the manufacturer in the medical device.

Make an Inquiry before Purchase @ goo.gl/bA4r6v

HbA1c testing device market is segmented on the basis of end user into hospitals, home care, diagnostic laboratory and research institution. Diagnostic laboratory segment dominated the market followed by home care segment and it is expected to grow at the highest rate in the forecast period. With increasing home care service and demand for homecare HbA1c testing device, homecare segment will exhibit significant growth in the forecast period.

Based on region, HbA1c testing device market is segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa. With more than 44 million diabetic populations North America dominated the market has the strong presence in the HbA1c testing device market. With increasing cases of diabetic cases and increasing medical tourism Asia-Pacific is expected to experience high growth in the forecast period.

Key operating players in HbA1c testing device market are like Transasia Biomedicals ltd., Abbott Laboratories, Alere, Inc., Arkray, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare and Trinity Biotech plc.

Browse detail report with in-depth TOC @ goo.gl/CPZLKu

HbA1c Testing Device Market: Device Type Analysis

  • Handheld Device
  • Bench-top Device

HbA1c Testing Device Market: Technology Type Analysis

  • Ion-exchange HPLC
  • Enzymatic assay
  • Affinity binding chromatography
  • Turbidimetric inhibition immunoassay
  • Other

HbA1c Testing Device Market: Device Type Analysis

  • Hospital
  • Homecare
  • Diagnostic laboratory

HbA1c Testing Device Market: Regional Type Analysis

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

About Us

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

You Might Also Like